Form 4 for AURA Aura Biosciences, Inc.
Accepted 2024-10-21 00:00:00 ET · period of report 2024-10-18 · accession 0000950170-24-116029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-10-21 | 2024-10-18 | AURA | Feder Julie B | CFO | S - Sale+OE | $12.03 | -25.1K | 134.3K | -16% | -$302.3K |
| DMT | 2024-10-21 | 2024-10-18 | AURA | Feder Julie B | CFO | M - OptEx | $3.44 | +25.1K | 159.4K | +19% | +$86.5K |
| DMT | 2024-10-21 | 2024-10-18 | AURA | Feder Julie B | CFO | M - OptEx | $0.00 | -25.1K | 32.4K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-18 | S | D | 25,131 | $12.03 | 134,276 | D | — | — | (F2) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.0000 to $12.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-10-18 | M | A | 17,500 | $2.74 | 151,776 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-18 | M | A | 2,631 | $4.25 | 154,407 | D | — | — | |
| 4 | Common | Common Stock | 2024-10-18 | M | A | 5,000 | $5.48 | 159,407 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-10-18 | M | D | 17,500 | $0.00 | 68,257 | D | $2.74 · — to 2028-10-03 | 17,500 Common Stock | (F3) This option is fully vested. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-10-18 | M | D | 5,000 | $0.00 | 120,547 | D | $5.48 · — to 2031-06-28 | 5,000 Common Stock | (F4) The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following June 28, 2021. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-10-18 | M | D | 2,631 | $0.00 | 32,359 | D | $4.25 · — to 2030-03-16 | 2,631 Common Stock | (F3) This option is fully vested. |